
Biocon subsidiary secures FDA approval for critical blood pressure medication
Biocon Pharma Limited, a wholly owned subsidiary of Biocon Limited, has received U.S. Food and Drug Administration (FDA) approval for its Abbreviated New Drug Application (ANDA) for Norepinephrine Bitartrate Injection USP, the company announced today. The …